Literature DB >> 18341967

Yttrium-90-labeled microsphere radioembolotherapy of liver-dominant metastases from thoracic malignancies.

Ravi Murthy, Pritesh Mutha, Jae Hoo Lee, Yun Oh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18341967     DOI： 10.1016/j.jvir.2007.11.002

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN： 1051-0443            Impact factor:   3.464


× No keyword cloud information.
  5 in total

Review 1.  Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

Authors:  Aaron K T Tong; Yung Hsiang Kao; Chow Wei Too; Kenneth F W Chin; David C E Ng; Pierce K H Chow
Journal:  Br J Radiol       Date:  2016-03-24       Impact factor: 3.039

Review 2.  Yttrium-90 microspheres: a review of its emerging clinical indications.

Authors:  Natthida Khajornjiraphan; Nyein Aye Thu; Pierce Kah Hoe Chow
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

Review 3.  Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors.

Authors:  Andrew Kuei; Sammy Saab; Sung-Ki Cho; Stephen T Kee; Edward Wolfgang Lee
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

Review 4.  The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.

Authors:  Mark A Westcott; Douglas M Coldwell; David M Liu; Joseph F Zikria
Journal:  Adv Radiat Oncol       Date:  2016-08-18

5.  Yttrium-90 microsphere radioembolization for treatment of lung cancer hepatic metastases.

Authors:  Ron C Gaba; Janesh Lakhoo
Journal:  Case Rep Oncol       Date:  2012-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.